The Reasoning: After a thorough review, the agency found no clinical need for these drugs to be compounded when FDA-approved versions are available and not in shortage
The FDA removed tirzepatide from the shortage list in late 2024, which means compounding tirzepatide for the general patient population may no longer be legally permissible for 503B facilities
Clinical trials for semaglutide (including the STEP program for weight loss and SUSTAIN for diabetes) all used once-weekly dosing as the standard protocol
It has been shockingly easy to get adequate nutrition with medication, because of tools I use
This pricing remains flat regardless of your eventual dose level, meaning your price won't increase as your body's needs change
If nausea persists beyond the first 4 weeks or significantly impairs your daily function, your healthcare provider may recommend short-term use of prescription anti-nausea medications such as ondansetron (Zofran) or metoclopramide (Reglan)